AnemiaCongenital hypoplastic anemiaMicroangiopathic hemolytic anemiaFANC proteins: FANC proteins are a group of proteins associated with Fanconi anemia.Warm autoimmune hemolytic anemiaNon-sideropenic hypochromic anaemia: ==Basic Features==MacrocytosisElisha K. Green: Elisha K. Green (1839–1917) was an entrepreneur in Los Angeles, California, who "made a fortune out of windmills" and served for six years on the Common Council, the governing body of that city.Sideroblastic anemiaSickle-cell diseaseRefractory period (physiology): Refractoriness is the fundamental property of any object of autowave nature (especially excitable medium) not to respond on stimuli, if the object stays in the specific refractory state. In common sense, refractory period is the characteristic recovery time, a period of time that is associated with the motion of the image point on the left branch of the isocline \dot{u} = 0 (for more details, see also Reaction-diffusion and Parabolic partial differential equation).SLC19A2: Thiamine transporter 1, also known as thiamine carrier 1 (TC1) or solute carrier family 19 member 2 (SLC19A2) is a protein that in humans is encoded by the SLC19A2 gene. SLC19A2 is a thiamine transporter.Hemoglobin, alpha 2: Hemoglobin, alpha 2 also known as HBA2 is a gene that in humans codes for the alpha globin chain of hemoglobin.Uniform methods and rules: The Uniform methods and rules are documents by the Veterinary Services office of USDA’s Animal and Plant Health Inspection Service (APHIS) that specify the minimum standards for preventing, detecting, controlling, and/or eradicating a particular animal disease. APHIS in late 2004 had UM&Rs posted on bovine tuberculosis eradication, brucellosis, brucellosis in cervidae, equine infectious anemia, pseudorabies eradication, swine brucellosis control/eradication, and voluntary scrapie flock certification programCongenital hemolytic anemiaContinuous erythropoietin receptor activator: Continuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoiesis-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin.Congenital dyserythropoietic anemia type III: Congenital dyserythropoietic anemia type III (CDA III) is a rare autosomal dominant disorder characterized by macrocytic anemia, bone marrow erythroid hyperplasia and giant multlnucleate erythroblasts.http://hmg.Lizzie's LootIron stress repressed RNA: Iron stress repressed RNA (IsrR) is a cis-encoded antisense RNA which regulates the expression of the photosynthetic protein isiA. IsiA expression is activated by the Ferric uptake regulator protein (Fur) under iron stress conditions.Gestational thrombocytopeniaAnemia of prematurityHematinic: A hematinic is a nutrient required for the formation of blood cells in the process of hematopoiesis. The principle hematinics are iron, B12, and folate.Hematocrit: The hematocrit (Ht or HCT, British English spelling haematocrit), also known as packed cell volume (PCV) or erythrocyte volume fraction (EVF), is the volume percentage (%) of red blood cells in blood. It is normally 45% for men and 40% for women.ErythropoiesisLow-dose chemotherapy: Low-dose chemotherapy is being studied/used in the treatment of cancer to avoid the side effects of conventional chemotherapy. Historically, oncologists have used the highest possible dose that the body can tolerate in order to kill as many cancer cells as possible.FerritinRibose-5-phosphate isomerase deficiency: Ribose-5-phosphate isomerase deficiency (RPI deficiency, OMIM #608611) is a human disorder caused by mutations in the pentose phosphate pathway enzyme ribose-5-phosphate isomerase. With a single diagnosed patient, RPI deficiency is currently the rarest disease in the world.PallorAntileukemic drug: Antileukemic drugs, anticancer drugs that are used to treat one or more types of leukemia, include:Red blood cell distribution width: right|frame|Human red blood cellsTransfusion associated circulatory overloadBone marrow suppression: Bone marrow suppression or myelotoxicity (adjective myelotoxic) or myelosuppression is the decrease in production of cells responsible for providing immunity (leukocytes), carrying oxygen (erythrocytes), and/or those responsible for normal blood clotting (thrombocytes). Bone marrow suppression is a serious side effect of chemotherapy and certain drugs affecting the immune system such as azathioprine.Erythrocrine: Erythrocrine describes red blood cell or erythrocyte for production and release of signaling molecules. The term “erythrocrine“ was coined by Song et al.Heparin-induced thrombocytopeniaTemporal analysis of products: Temporal Analysis of Products (TAP), (TAP-2), (TAP-3) is an experimental technique for studyingTransplacental: Transplacental refers to the ability of a toxin or pathogen to cross the physical and biological barriers of the placenta separating the mother and fetus, to whom such substances may be dangerous. This would include, for example, HIV and the drug thalidomide.Coombs test: A Coombs test (also known as Coombs' test, antiglobulin test or AGT) is either of two clinical blood tests used in immunohematology and immunology. The two Coombs tests are the direct Coombs test (DCT, also known as direct antiglobulin test or DAT), and the indirect Coombs test (also known as indirect antiglobulin test or IAT).Immunosuppressive drug: Immunosuppressive drugs or immunosuppressive agents or antirejection medications are drugs that inhibit or prevent activity of the immune system. They are used in immunosuppressive therapy to:Concentration effect: In the study of inhaled anesthetics, the concentration effect is the increase in the rate that the Fa(alveolar concentration)/Fi(inspired concentration) ratio rises as the alveolar concentration of that gas is increased. In simple terms, the higher the concentration of gas administered, the faster the alveolar concentration of that gas approaches the inspired concentration.Non-communicable disease: Non-communicable disease (NCD) is a medical condition or disease that is non-infectious or non-transmissible. NCDs can refer to chronic diseases which last for long periods of time and progress slowly.Monoclonal antibody therapyCytarabineProtective index: The protective index is a comparison of the amount of a therapeutic agent that causes the therapeutic effect to the amount that causes toxicity. Quantitatively, it is the ratio given by the toxic dose divided by the therapeutic dose.Combination therapy: Combination therapy or polytherapy is therapy that uses more than one medication or modality (versus monotherapy, which is any therapy taken alone). Typically, these terms refer to using multiple therapies to treat a single disease, and often all the therapies are pharmaceutical (although it can also involve non-medical therapy, such as the combination of medications and talk therapy to treat depression).Potassium ferrateAnisocytosisBoronic acidBortezomibHosoya's triangle: Fibonacci triangle or the Hosoya's triangle is a triangular arrangement of numbers (like Pascal's triangle) based on the Fibonacci numbers. Each number is the sum of the two numbers above in either the left diagonal or the right diagonal.Psychological refractory period: The term psychological refractory period (PRP) refers to the period of time during which the response to a second stimulus is significantly slowed because a first stimulus is still being processed. This delay in response time when one is required to divide attention can exhibit a negative effect that is evident in many fields of study.Multiple Myeloma Research Foundation: right|240pxEpilepsy Research UK: Epilepsy Research UK is a British medical research charity dedicated to curing epilepsy.PancytopeniaClinical endpoint: In a clinical research trial, a clinical endpoint generally refers to occurrence of a disease, symptom, sign or laboratory abnormality that constitutes one of the target outcomes of the trial, but may also refer to any such disease or sign that strongly motivates the withdrawal of that individual or entity from the trial, then often termed humane (clinical) endpoint.Working Formulation: The Working formulation is an obsolete classification of non-Hodgkin lymphomas, first proposed in 1982. It has since been replaced by other lymphoma classifications, the latest published by the WHO in 2008, but is still used by cancer agencies for compilation of lymphoma statistics.Blood cell: A blood cell, also called a hemocyte, hematocyte, or hematopoietic cell, is a cell produced through hematopoiesis and is normally found in blood. In mammals, these fall into three general categories:Partial cloning: In the field of cell biology, the method of partial cloning (PCL) converts a fully differentiated old somatic cell into a partially reprogrammed young cell that retains all the specialised functions of the differentiated old cell but is simply younger. The method of PCL reverses characteristics associated with old cells.Nodular lymphocyte predominant Hodgkin's lymphomaHematopoietic stem cell transplantationVidarabineCancer survival rates: Cancer survival rates vary by the type of cancer, stage at diagnosis, treatment given and many other factors, including country. In general survival rates are improving, although more so for some cancers than others.Ornithinaemia: Ornithinaemia is a blood disorder characterized by high levels of ornithine. Also known as hyperornithinemia, it may be associated with psychomotor retardation or epileptic episodes.